What happens if your vitamin C is very low?

Vitamin C is one of the few nutrients the body can run down to empty in a matter of weeks.

Symptoms start to appear after 4 to 12 weeks of insufficient intake, and the first of them look like ordinary tiredness rather than a nutrient problem. About 6.8% of US adults sit below the deficiency threshold.

What follows is a sequence, not a single event: energy first, then collagen, then immunity and iron. Here is the order it happens in, and how fast it reverses.

Table of Contents

1. What "Very Low" Actually Means
2. Energy Goes First
3. Collagen Is the Structural Failure
4. Immunity and Iron Follow
5. The Timeline, in Both Directions
6. Who Actually Ends Up Low
7. Where Absorption Starts to Matter
8. Bio Absorb Liposomal Vitamin C — Corn-Free, in Two Formats
9. Frequently Asked Questions
10. Conclusion

1. What "Very Low" Actually Means

"Very low" is a blood measurement, not a feeling. Deficiency is generally defined as plasma or serum vitamin C below 11.4 µmol/L, the level at which signs of deficiency can start to appear. Above that line sits a wide grey band: researchers describe hypovitaminosis C as plasma under 23 µmol/L, which is relatively common in Western populations and is not the same thing as deficiency.

The reason the two states feel so different comes down to how much vitamin C the body is holding. The total pool is around 1,500 mg, and clinical signs appear once that drops below roughly 350 mg. On the intake side, overt symptoms arrive only when intake falls below about 10 mg a day for many weeks, against an adult RDA of 90 mg for men and 75 mg for women.

It is a slope rather than a switch, and the slope is steepest at the bottom. In the depletion study behind the current RDA, steady-state plasma concentration followed a sigmoid curve, with the steep portion falling between the 30 and 100 mg daily doses. Small changes in intake move blood levels a great deal when intake is already low, and barely move them at all once intake is adequate.

2. Energy Goes First

Long before anything is visible, low vitamin C shows up as tiredness. Vitamin C is required for the biosynthesis of collagen, L-carnitine and certain neurotransmitters, and the fatigue of early deficiency is thought to come from impaired carnitine production in particular — carnitine being the molecule that moves fatty acids into cells to be burned for energy.

The clinical picture matches. The first symptoms to emerge, after 4 to 12 weeks of insufficient intake, are non-specific ones: fatigue, malaise, lethargy and loss of appetite. Nothing about them points at a vitamin.

That is exactly why a symptom checklist is a weak tool here. Fatigue has dozens of more likely explanations than vitamin C, and persistent tiredness warrants a proper medical workup rather than a supplement. If you are trying to match symptoms to a cause, our guide to the signs and symptoms of vitamin C deficiency covers that ground in detail.

3. Collagen Is the Structural Failure

The visible stage of deficiency is a collagen problem. Vitamin C is a cofactor for proline and lysine hydroxylases, the enzymes that stabilise collagen types I and VI. Without it, those enzymes cannot do their job, and the body keeps making collagen that will not hold its shape.

That matters because collagen is structural almost everywhere. It makes up 75% of the dermis, and type IV collagen is the primary building block of blood-vessel walls. When the walls of small vessels weaken, they leak. That is the mechanism behind nearly every classic sign:

• Bleeding into the skin — petechiae, bruising and purpura, often on the legs first
• Bleeding gums and, in advanced cases, loosening teeth
• Wounds that heal slowly, because repair tissue needs new collagen
• Joint and bone pain, from the same fragility in connective tissue

The full progression runs through petechiae, ecchymoses, purpura, joint pain, poor wound healing, hyperkeratosis and corkscrew hairs. None of it reads as a nutrient deficiency to someone experiencing it, which is a large part of why it is missed.

4. Immunity and Iron Follow

Vitamin C concentrates in white blood cells. Neutrophils, monocytes and lymphocytes hold concentrations at least 14 times higher than plasma, and they saturate at around 100 mg of daily intake. Those cells use it: vitamin C supports chemotaxis, phagocytosis and microbial killing, and deficiency results in impaired immunity and higher susceptibility to infections.

It is worth being precise about what that does and does not mean. Most of the studies behind those findings involved people whose status was already marginal or deficient, and the same review notes that supplementation in people with adequate status may not produce comparable effects. Correcting a shortfall is not the same as topping up a full tank — a distinction our article on vitamin C and immune function works through properly.

Iron is the other casualty. Vitamin C improves the absorption of non-haem iron, the form found in plant foods, so low status quietly reduces how much iron a meal delivers. Combined with the bleeding that comes from fragile vessels, this is why iron-deficiency anaemia often travels alongside severe deficiency. The mechanics of that pairing are covered in our piece on vitamin C and iron absorption.

5. The Timeline, in Both Directions

Going down takes longer than most people assume. Signs can appear within about a month of little or no vitamin C intake, and the broader clinical window is 4 to 12 weeks of insufficient intake. A bad fortnight of eating will not do it.

Coming back up is faster, and it happens in a predictable order once intake is restored:

• Within 24 hours — fatigue, body aches and appetite typically start to improve
• Within 1 to 2 weeks — bruising, gum bleeding and bleeding around hair follicles respond
• Within 1 month — corkscrew hairs usually return to normal
• Within 3 months — most signs tend to resolve completely

Two caveats sit on that list. The first is that several of these signs overlap with conditions that are not nutritional and some of which are serious, including bleeding disorders, so scurvy should be confirmed and treated by a doctor rather than self-diagnosed. The second is that recovery depends on fixing whatever caused the shortfall; the same analyses that document scurvy also report relapse when the underlying cause goes unaddressed.

6. Who Actually Ends Up Low

Deficiency is not distributed evenly, and the pattern is more socioeconomic than dietary fashion. In US national survey data, deficiency affected 9.8% of adults in the lowest income group against 4.6% in the highest. Mean serum vitamin C was 15 µmol/L lower in smokers than non-smokers and 11 µmol/L lower in people with obesity than those at a healthy weight.

Two trends are pulling in opposite directions. Overall prevalence has barely moved — 6.8% in 2017–2018 against 7.0% in 2003–2006 — yet dietary intake fell by roughly 13% across the same period, with supplement use making up some of the gap. Among adults taking a vitamin C–containing supplement, deficiency was 0.5%.

At the severe end, the picture is less reassuring. Among US paediatric hospital admissions, scurvy rose from 8.2 to 26.7 per 100,000 between 2016 and 2020, with 36.5% of cases from the lowest income quartile. In France, an analysis of 888 children hospitalised for scurvy between 2015 and 2023 found the increase correlated with the consumer price index. Smokers are a separate case with measurably higher requirements, covered in our article on vitamin C for smokers.

7. Where Absorption Starts to Matter

Correcting a shortfall runs into a design constraint. Absorption is efficient at modest intakes — 70% to 90% at intakes of 30 to 180 mg a day — but falls away above that. At doses above 1 g a day, absorption drops below 50%, and in the depletion study, bioavailability was complete for a single 200 mg dose but declined at single doses of 500 mg and above. Our guide to why most of your vitamin C dose is wasted explains the transporter saturation behind that.

This is the gap liposomal delivery is meant to address, by encapsulating ascorbate in phospholipids so it is not wholly dependent on those saturable transporters. A 2025 scoping review found that nine of ten trials showed higher bioavailability for liposomal ascorbate, with 1.3 to 7.2-fold higher AUC. The UK Committee on Toxicity reached a broadly similar read, while noting there are only a handful of controlled human studies on the question.

The honest caveat matters more than usual on this page. The same 2025 review calls for future studies to assess participants with low baseline status — which is to say the liposomal trials have been run almost entirely in people who were not short of vitamin C to begin with. The absorption advantage is reasonably well evidenced; what it does for someone who is genuinely low has not been tested directly. Anyone wanting the full picture can start with our complete guide to liposomal vitamin C.

8. Bio Absorb Liposomal Vitamin C — Corn-Free, in Two Formats

Bio Absorb Nutraceuticals makes liposomal vitamin C in a liquid and a capsule format, both built around the same formulation and the same allergen profile. The phospholipid encapsulation is the point: it is the delivery approach the research above is describing, rather than a different active ingredient.

The attribute worth singling out is that both are verified corn-free. Nearly all commercial ascorbic acid is derived from corn, and most liposomal brands do not address it at all, which makes this one of the few genuinely checkable differences in the category. Alongside that, both formats are non-GMO, gluten-free, nut-free, dairy-free and vegan.

They are made in Canada in a GMP-certified facility, are non-irradiated, and are third-party tested every batch, with a certificate of analysis available on request. Choosing between the formats is practical rather than technical. The liquid mixes into water or juice, which suits flexible dosing. The capsules need no refrigeration and have no taste, which suits travel and routine. Both are covered by a 100% money-back guarantee, and empty bottles do not need to be returned.

None of this is a treatment for deficiency. Anyone with signs of scurvy needs a clinician, not a supplement aisle. For anyone whose intake is simply falling short, see the current serving details and pricing for Bio Absorb's Liposomal Vitamin C, which stay up to date on the product page.

Frequently Asked Questions

How low is "very low"?

Deficiency is defined as plasma vitamin C below 11.4 µmol/L. There is a separate, wider category above it — hypovitaminosis C, under 23 µmol/L — which is far more common and produces no visible signs at all. Most people who worry they are low are somewhere in that upper band rather than near the deficiency threshold.

How long does it take to get there?

Typically 4 to 12 weeks of insufficient intake, and symptoms appear only when intake drops below roughly 10 mg a day for many weeks. The body holds a buffer of around 1,500 mg, which has to be drawn down to about 350 mg before clinical signs show.

What is usually the first thing people notice?

Tiredness, along with low mood and reduced appetite, which are among the first signs the NIH lists. They are also some of the least specific symptoms in medicine, so they are a poor basis for self-diagnosis. Persistent fatigue is worth investigating properly rather than treating with a supplement.

How quickly does it reverse?

Quickly, and in stages. Fatigue and body aches typically improve within 24 hours of treatment, with bruising and gum bleeding responding within 1 to 2 weeks and most signs resolving within 3 months. Treatment should be supervised by a doctor, since several signs overlap with more serious conditions.

Can I be low without being deficient?

Yes, and that is by far the more common situation. Hypovitaminosis C is relatively common in Western populations, while frank deficiency affects roughly 6.8% of US adults. The two are different problems with different consequences.

Is there a limit to how much I should take to correct it?

The tolerable upper intake level for adults is 2,000 mg a day, counting food and supplements together, above which gastrointestinal upset becomes common. Anyone with kidney disease, a history of kidney stones, an iron-overload condition such as haemochromatosis, or who takes regular medication should speak to a physician before supplementing. Our guide to vitamin C dosage goes through the ranges in detail.

Conclusion

Very low vitamin C is a sequence rather than an event: energy first, collagen next, then immunity and iron, over 4 to 12 weeks. The more useful question for most readers is not whether they are deficient but where they sit on the long gradient above that line, and whether their intake is actually reaching them. If supplementing is part of your answer, see the current serving details for Bio Absorb Nutraceuticals Liposomal Vitamin C.

Research References

1. Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance. Proceedings of the National Academy of Sciences USA, Vol. 93, Issue 8 (1996). In-hospital depletion–repletion study in seven men; source for the sigmoid dose–plasma relationship, the steep 30–100 mg region, complete bioavailability at a single 200 mg dose, and leukocyte concentrations at least 14-fold higher than plasma.
2. Vitamin C and Immune Function. Nutrients, Vol. 9, Issue 11, article 1211 (2017). Source for vitamin C's role in neutrophil chemotaxis, phagocytosis and microbial killing, the definition of hypovitaminosis C below 23 µmol/L, and the caveat that most supporting studies began from marginal or deficient status.
3. Vitamin C status of US adults assessed as part of the National Health and Nutrition Examination Survey remained unchanged between 2003–2006 and 2017–2018. The Journal of Applied Laboratory Medicine, Vol. 8, Issue 2 (2023). Source for the 6.8% versus 7.0% deficiency prevalence, the income and smoking gradients, the 0.5% figure among supplement users, and the approximate 13% decline in dietary intake.
4. The Troubling Rise of Scurvy: A Review and National Analysis of Incidence, Associated Risk Factors, and Clinical Manifestations. JAAOS: Global Research and Reviews, Vol. 8, Issue 7 (2024). US inpatient analysis showing paediatric scurvy incidence rising from 8.2 to 26.7 per 100,000 between 2016 and 2020, concentrated in the lowest income quartile.
5. Scurvy incidence trend among children hospitalised in France, 2015–2023: a population-based interrupted time-series analysis. The Lancet Regional Health — Europe, Vol. 49 (2025). Population-based analysis of 888 hospitalised children, documenting a post-2020 rise correlated with the consumer price index.
6. Do Liposomal Vitamin C Formulations Have Improved Bioavailability? A Scoping Review Identifying Future Research Directions. Basic & Clinical Pharmacology & Toxicology, Vol. 137, Issue 1 (2025). Reports 1.3–7.2-fold higher AUC for liposomal forms in nine of ten trials, and identifies the absence of trials in participants with low baseline status as an open research gap.
7. Vitamin C — Fact Sheet for Health Professionals. National Institutes of Health, Office of Dietary Supplements (updated 2025). Source for the approximate 10 mg/day deficiency threshold, the adult RDAs, the 2,000 mg/day tolerable upper intake level, the collagen–carnitine–neurotransmitter biosynthesis role, non-haem iron absorption, the progression of clinical signs, and absorption of 70–90% at 30–180 mg/day.
8. Vitamin C Deficiency. StatPearls, National Center for Biotechnology Information (updated 2023). Source for the 4–12 week symptom onset window, the 1,500 mg body pool and 350 mg signs threshold, the proline and lysine hydroxylase cofactor role, collagen as 75% of the dermis, and the staged recovery timeline.
9. National Report on Biochemical Indicators of Diet and Nutrition — Water-Soluble Vitamin C. US Centers for Disease Control and Prevention (2026). Source for the 11.4 µmol/L deficiency threshold and the scurvy intake threshold below 10 mg/day.
10. Discussion paper on novel formulations of supplement compounds designed to increase oral bioavailability — Case study 1: Liposomal vitamin C. UK Committee on Toxicity (2025). Independent assessment finding that liposomal preparations appear to increase oral bioavailability, while noting only a handful of controlled human studies exist.

About the Author

David Kimbell is a health writer, digital entrepreneur and former aerospace engineer, based in Ottawa, Canada. He loves translating complex science into clear, actionable guidance for consumers seeking evidence-based solutions.

---

Important Disclaimers

Medical Disclaimer: This article provides educational information only and is not intended as medical advice. Always consult with a qualified healthcare provider before starting any new supplement, especially if you have existing health conditions, take medications, or are pregnant or nursing.

FDA/Health Canada Statement: These statements have not been evaluated by the Food and Drug Administration or Health Canada. This product is not intended to diagnose, treat, cure, or prevent any disease.